4//SEC Filing
Wallace Owen B. 4
Accession 0001209191-24-000768
CIK 0001826457other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:15 PM ET
Size
6.4 KB
Accession
0001209191-24-000768
Insider Transaction Report
Form 4
Wallace Owen B.
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-01-02+119,000→ 119,000 totalExercise: $5.71Exp: 2034-01-01→ Common Stock (119,000 underlying)
Holdings
- 5,266
Common Stock
Footnotes (2)
- [F1]Includes an aggregate of 5,266 shares previously acquired under the Issuer's 2021 Employee Stock Purchase Plan.
- [F2]25% of this option shall vest and become exercisable on January 1, 2025, with the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
Documents
Issuer
Monte Rosa Therapeutics, Inc.
CIK 0001826457
Entity typeother
Related Parties
1- filerCIK 0001778843
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 4:15 PM ET
- Size
- 6.4 KB